Oana Ancu

Dr. Oana Ancu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in IEEE Sensors Journal
Verified
Journal Article
Closed access
YSYuyang Sun
Yuyang Sun
HCHelena Cano-Garcia
Helena Cano-Garcia
EKEfthymios Kallos
Efthymios Kallos
FOFergus O’brien
Fergus O’brien
AAAdeyemi Akintonde
Adeyemi Akintonde
Panagiotis KosmasPanagiotis Kosmas
Panagiotis Kosmas
Recently, great progress has been achieved in diabetes management through minimally invasive continuous glucose monitoring, which involves piercing the skin to identify changes in glucose levels in the interstitial fluid. Nevertheless, the development of accurate fully non-invasive glucose monitors remains a topic of great interest. This work examines the processing of data collected from a multi-sensor system, which combines millimeter-wave, near-infrared, and other auxiliary sensors’ technology, coupled with a random forest machine learning model for prediction. We investigated possible correlations between millimeter-wave, near-infrared, skin temperature, pressure data, and blood glucose values, and deployed a machine learning model for prediction. The model is based on the random forest algorithm that was trained and tested on data collected from a study involving five healthy human subjects undergoing an intravenous glucose tolerance test. Our model achieves a root mean squared error of 21.06 mg/dl and a mean absolute relative difference of 7.31% for glucose prediction in the collected clinical subjects dataset. Additionally, 96.1% of the model’s predictions fall within the clinically acceptable zones according to the Clarke error grid analysis. The preliminary results suggest that combining multiple sensor data with machine learning techniques is promising for the development of non-invasive glucose monitoring.

1 January 2021 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
OAOana Ancu
Oana Ancu
MMMonika Mickute
Monika Mickute
NGNicola Guess
Nicola Guess
NHNicholas M. Hurren
Nicholas M. Hurren
NBNicholas Burd
Nicholas Burd
RMRichard W. A. Mackenzie
Richard W. A. Mackenzie
Insulin resistance is a complex metabolic disorder implicated in the development of many chronic diseases. While it is generally accepted that body mass loss should be the primary approach for the management of insulin resistance-related disorders in overweight and obese individuals, there is no consensus among researchers regarding optimal protein intake during dietary restriction. Recently, it has been suggested that increased plasma branched-chain amino acids concentrations are associated with the development of insulin resistance and type 2 diabetes. The exact mechanism by which excessive amino acid availability may contribute to insulin resistance has not been fully investigated. However, it has been hypothesised that mammalian target of rapamycin (mTOR) complex 1 hyperactivation in the presence of amino acid overload contributes to reduced insulin-stimulated glucose uptake because of insulin receptor substrate (IRS) degradation and reduced Akt-AS160 activity. In addition, the long-term effects of high-protein diets on insulin sensitivity during both weight-stable and weight-loss conditions require more research. This review focusses on the effects of high-protein diets on insulin sensitivity and discusses the potential mechanisms by which dietary amino acids can affect insulin signalling. Novelty: Excess amino acids may over-activate mTOR, resulting in desensitisation of IRS-1 and reduced insulin-mediated glucose uptake.